January 30, 2024 TRxA 2024 Funding Opportunities TRxA’s focus is translating early-stage novel therapeutics into Investigational New Drug (IND) supporting data packages that...
December 8, 2023 Understanding the Role of Patient Data in Drug Development Panel within a session titled “Understanding the role of patient data in drug development” at the 2023 International...
November 16, 2023 Poster: C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
ASN PKDOC Poster — November 2023: Despite the regulatory advances in ADPKD including the qualification of total kidney volume (TKV) as a prognostic enrichment bioma
August 9, 2023 C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy C-Path's Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce...
April 27, 2023 Clinical Outcome Assessments: Does one size fit all? This webinar is presented jointly by the Rare Disease COA Consortium and C-Path’s Rare Disease Cures Accelerator-Data and...
July 6, 2023 Worldwide collaborative framework for optimizing new Parkinson’s treatment trials with patient centric outcome measures
June 15, 2023 US and UK policy responses to the challenges of repurposing approved drugs for new indications